Guillain–Barré Syndrome and COVID-19 Vaccine: A Multicenter Retrospective Study of 46 Cases
- 1 September 2023
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of Clinical Neuromuscular Disease
- Vol. 25 (1) , 1-10
Abstract
In the context of the global vaccination campaign against COVID-19, several cases of postvaccinal Guillain–Barré syndrome (GBS) were reported. Whether a causal relationship exists between these events has yet to be established. We investigated the clinical and electromyographic characteristics of patients who developed GBS after COVID-19 vaccination and compare these with findings in patients with GBS, without a history of recent vaccination. We included 91 cases between March 2020 and March 2022, treated at 10 referral hospitals of Buenos Aires, Argentina. Of these, 46 had received vaccination against COVID-19 within the previous month. Although Medical Research Council sum-scores were similar in both groups (median 52 vs. 50; P = 0.4), cranial nerve involvement was significantly more frequent in the postvaccination group (59% vs. 38%; P = 0.02), as was bilateral facial paralysis (57% vs. 24%; P = 0.002). No differences were found in clinical or neurophysiological phenotypes, although 17 subjects presented the variant of bilateral facial palsy with paresthesias (11 vs. 6; P = 0.1); nor were significant differences observed in length of hospital stay or mortality rates. Future vaccine safety monitoring and epidemiology studies are essential to demonstrate any potential causal relationship between these events.Keywords
This publication has 24 references indexed in Scilit:
- Guillain-Barre Syndrome, Influenza, and Influenza Vaccination: The Epidemiologic EvidenceClinical Infectious Diseases, 2014
- Guillain–Barré SyndromeNew England Journal of Medicine, 2012
- Guillain-Barré Syndrome: Modern Theories of EtiologyCurrent Allergy and Asthma Reports, 2011
- Population Incidence of Guillain-Barré Syndrome: A Systematic Review and Meta-AnalysisNeuroepidemiology, 2011
- Early recognition of poor prognosis in Guillain-Barré syndromeNeurology, 2011
- Vaccines and Guillain-Barré SyndromeDrug Safety, 2009
- Guillain-Barré syndromeThe Lancet, 2005
- Electrophysiological classification of guillain‐barré syndrome: Clinical associations and outcomeAnnals of Neurology, 1998
- Interobserver agreement in the assessment of muscle strength and functional abilities in Guillain‐Barré syndromeMuscle & Nerve, 1991
- CONTROLLED TRIAL OF PREDNISOLONE IN ACUTE POLYNEUROPATHYThe Lancet, 1978